Oxidative Stress and the Myelodysplastic Syndromes
β Scribed by Morag J. Farquhar; David T. Bowen
- Book ID
- 105675570
- Publisher
- Carden Jennings Publishing
- Year
- 2003
- Tongue
- English
- Weight
- 173 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
T he article by Ferrara et al. 1 in this issue of Cancer describes the treatment of patients with poor prognosis myelodysplastic syndromes (MDS) using intensive remission induction chemotherapy followed by peripheral blood stem cell transplantation for patients age Ο½ 60 years. Thirty-two patients wi
## Abstract ## BACKGROUND The assessment of patients with myelodysplastic syndromes (MDS) and the choice of therapies remain challenging. New therapies are now emerging after the identification of molecular targets that result in improvement of hematologic parameters and may hold promise for the p
We have studied telomere length in the bone marrow cells or the granulocyte and lymphocyte cell fractions of 54 patients with myelodysplastic syndromes (MDS) by Southern blot hybridization using the (TTAGGG)4 probe. The average telomere length expressed as the peak telomere repeat array (TRA) in the